دورية أكاديمية

Varicella vaccination in Europe: are we ready for a universal childhood programme?

التفاصيل البيبلوغرافية
العنوان: Varicella vaccination in Europe: are we ready for a universal childhood programme?
المؤلفون: Sengupta, Nitu, Booy, Robert, Schmitt, H. J., Peltola, Heikki, Van-Damme, Pierre, Schumacher, R. Fabian, Campins, Magda, Rodrigo, Carlos, Heikkinen, Terho, Seward, Jane, Jumaan, Aisha, Finn, Adam, Olcén, Per, Thiry, Nancy, Weil-Olivier, Catherine, Breuer, Judith, Olcén, Per
المصدر: European Journal of Pediatrics; Jan2008, Vol. 167 Issue 1, p47-55, 9p, 2 Charts, 1 Graph
مصطلحات موضوعية: VACCINES, DISEASES, IMMUNIZATION, CHICKENPOX, HERPES zoster, COMPARATIVE studies, HOSPITAL care, MATHEMATICAL models, RESEARCH methodology, MEDICAL cooperation, HEALTH policy, MEDICAL protocols, RESEARCH, THEORY, EVALUATION research, CHICKENPOX vaccines, PREVENTION
مصطلحات جغرافية: EUROPE
مستخلص: Safe and effective vaccines against varicella zoster virus (VZV), the aetiological agent of varicella and shingles, have been available in Europe for the last 5-10 years. The USA has had a universal childhood vaccination policy since 1995 and this has resulted in a dramatic decrease in the incidence, morbidity and mortality related to varicella. The economic and medical burden of VZV has led to discussions regarding both the desirability and feasibility of a similar routine immunisation policy for all European children. This article examines the epidemiology of varicella in Europe and how the data emerging from the USA can be used to achieve adequate prevention of the disease. It looks into the current evidence of the health economic evaluation of universal varicella vaccination and explores the concerns surrounding such a policy, including the postulated impact on the incidence of zoster. In conclusion, the Society of Independent European Vaccination Experts (SIEVE) recommends that the immunisation of susceptible adolescents needs to be urgently implemented, in addition to the current recommendations targeting high-risk patients, their close contacts with a negative history of varicella and seronegative health-care workers. A universal policy, optimally incorporating a two-dose schedule, will be needed to finally reduce the burden of disease of varicella from a societal point of view. The SIEVE recommends the implementation of such a policy as soon as financially and practically possible. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Pediatrics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03406199
DOI:10.1007/s00431-007-0424-0